Association between interferon response and protective efficacy of NS1-truncated mutants as influenza vaccine candidates in chickens

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Jang, Hyesun ^a,b   Ngunjiri, John M ^a   Lee, Chang Won ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; INFLUENZA VACCINE; INTERFERON; NONSTRUCTURAL PROTEIN 1; RECOMBINANT ALPHA INTERFERON; INS1 PROTEIN, INFLUENZA VIRUS; LIVE VACCINE; RECOMBINANT PROTEIN; VIRAL PROTEIN; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHICKEN; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; GENE INDUCTION; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA; NONHUMAN; PROTECTION; PROTEIN INDUCTION; VIRUS MUTANT; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; INFLUENZA IN BIRDS; MUTATION; ORAL DRUG ADMINISTRATION; VIROLOGY;

ADAPTIVE IMMUNITY; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INTERFERONS; MUTATION; RECOMBINANT PROTEINS; VACCINES, ATTENUATED; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84973464862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156603     Document Type: Article

References (52)

1. Bean WJ, Kawaoka Y, Wood JM, Pearson JE, Webster RG. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol. 1985; 54(1):151-60. Epub 1985/04/01. PMID: 3973976; PubMed Central PMCID: PMCPMC254772.
2. Capua I, Mutinelli F, Pozza MD, Donatelli I, Puzelli S, Cancellotti FM. The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications. Acta Trop. 2002; 83(1):7-11. Epub 2002/06/14. PMID: 12062787.
3. Cyranoski D. Outbreak of chicken flu rattles Hong Kong. Nature. 2001; 412(6844): 261.
4. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004; 101(5):1356-61. Epub 2004/01/28. doi: 10.1073/pnas.0308352100 PMID: 14745020; PubMed Central PMCID: PMCPMC337057.
5. Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol. 2004; 33(4):393-404. Epub 2004/09/17. doi: 10.1080/03079450410001724085 PMID: 15370036.
6. Hvistendahl M. Avian influenza. Enigmatic bird flu strain races across the U.S. Midwest. Science. 2015; 348: 741-2. doi: 10.1126/science.348.6236.741 PMID: 25977528
7. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002; 34 Suppl 2:S58-64. Epub 2002/04/09. doi: 10.1086/338820 PMID: 11938498.
8. Feng L, Wu JT, Liu X, Yang P, Tsang TK, Jiang H, et al. Clinical severity of human infections with avian influenza A(H7N9) virus, China, 2013/14. Euro Surveill. 2014; 19(49). Epub 2014/12/20. PMID: 25523971; PubMed Central PMCID: PMCPMC4454636.
9. Tang RB, Chen HL. An overview of the recent outbreaks of the avian-origin influenza A (H7N9) virus in the human. J Chin Med Assoc. 2013; 76(5):245-8. Epub 2013/05/09. doi: 10.1016/j.jcma.2013.04.003 PMID: 23651506.
10. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004; 363(9409):587-93. Epub 2004/02/28. doi: 10.1016/s0140-6736(04)15589-x PMID: 14987882.
11. Swayne DE, Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev. 2008; 225:314-31. Epub 2008/10/08. doi: 10.1111/j.1600-065X.2008.00668.x PMID: 18837791.
12. Lee CW, Suarez DL. Avian influenza virus: prospects for prevention and control by vaccination. Anim Health Res Rev. 2005; 6(1):1-15. Epub 2005/09/17. PMID: 16164006.
13. Elaish M, Kang KI, Xia M, Ali A, Shany SA, Wang L, et al. Immunogenicity and protective efficacy of the norovirus P particle-M2e chimeric vaccine in chickens. Vaccine. 2015; 33(38):4901-9. Epub 2015/08/02. doi: 10.1016/j.vaccine.2015.07.049 PMID: 26232342.
14. Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med. 2013; 64:189-202. Epub 2013/01/19. doi: 10.1146/annurev-med-120611-145115 PMID: 23327522.
15. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1998; 252(2):324-30. Epub 1999/01/08. PMID: 9878611.
16. Richt JA, Garcia-Sastre A. Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol. 2009; 333:177-95. Epub 2009/09/22. doi: 10.1007/978-3-540-92165-3-9 PMID: 19768406.
17. Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, Garcia-Sastre A, Saif YM, et al. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine. 2008; 26(29-30):3580-6. Epub 2008/06/10. doi: 10.1016/j.vaccine.2008.05.001 PMID: 18539366; PubMed Central PMCID: PMCPMC2785844.
18. Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, Lee CW. In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J Virol. 2010; 84(21):10974-81. Epub 2010/08/27. doi: 10.1128/jvi.00502-10 PMID: 20739541; PubMed Central PMCID: PMCPMC2953188.
19. Ngunjiri JM, Lee CW, Ali A, Marcus PI. Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells co-infected with defective-interfering particles. J Interferon Cytokine Res. 2012; 32(6):280-5. Epub 2012/03/06. doi: 10.1089/jir.2011.0102 PMID: 22385205.
20. Lee CW. Reverse genetics of influenza virus. Methods Mol Biol. 2014; 1161:37-50. doi: 10.1007/978-1-4939-0758-8-4 PMID: 24899418
21. Ibrahim M, Sultan HA, Razik AG, Kang KI, Arafa AS, Shehata AA, et al. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses. Vaccine. 2015; 33(23):2670-7. doi: 10.1016/j.vaccine.2015.04.023 PMID: 25910922
22. Sekellick MJ, Ferrandino AF, Hopkins DA, Marcus PI. Chicken interferon gene: cloning, expression, and analysis. J Interferon Res. 1994; 14(2):71-9. PMID: 7521382
23. Pawar SD, Murtadak VB, Kale SD, Shinde PV, Parkhi SS. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation. J Virol Methods. 2015; 222:28-33. doi: 10.1016/j.jviromet.2015.05.004 PMID: 25997377
24. Jang H, Koo BS, Jeon EO, Lee HR, Lee SM, Mo IP. Altered pro-inflammatory cytokine mRNA levels in chickens infected with infectious bronchitis virus. Poult Sci. 2013; 92(9):2290-8. doi: 10.3382/ps.2013-03116 PMID: 23960111
25. Kapczynski DR, Jiang HJ, Kogut MH. Characterization of cytokine expression induced by avian influenza virus infection with real-time RT-PCR. Methods Mol Biol. 2014; 1161:217-33. doi: 10.1007/978-1-4939-0758-8-18 PMID: 24899432
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. PMID: 11846609
27. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, et al. Development of a realtime reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002; 40(9):3256-60. PMID: 12202562
28. Lee CW, Suarez DL. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J Virol Methods. 2004; 119(2):151-8. PMID: 15158597
29. Reed L, Muench H. A simple method of estimating fifty percent endpoints. American Journal of Epidemiology. 1938; 27(3):493-7.
30. Meng S, Yang L, Xu C, Qin Z, Xu H, Wang Y, et al. Recombinant chicken interferon-α inhibits H9N2 avian influenza virus replication in vivo by oral administration. J Interferon Cytokine Res. 2011; 31 (7):533-8. doi: 10.1089/jir.2010.0123 PMID: 21323426
31. Liang J, Fu J, Kang H, Lin J, Yu Q, Yang Q. Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken. Poult Sci. 2013; 92(10):2651-60. doi: 10.3382/ps.2013-03193 PMID: 24046412
32. Stone HD. Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avian Dis. 1987; 31(3):483-90. PMID: 2960309
33. Ngunjiri JM, Ali A, Boyaka P, Marcus PI, Lee CW. In Vivo Assessment of NS1-Truncated Influenza Virus with a Novel SLSYSINWRH Motif as a Self-Adjuvanting Live Attenuated Vaccine. PLoS One. 2015; 10(3):e0118934. doi: 10.1371/journal.pone.0118934 PMID: 25790187
34. Bracci L, Canini I, Venditti M, Spada M, Puzelli S, Donatelli I, et al. Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus. Vaccine. 2006; 24 Suppl 2:S2-56-7.
35. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, Rossmann C, et al. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol. 2006; 176 (8):4682-9. PMID: 16585561
36. Nagao Y, Yamashiro K, Hara N, Horisawa Y, Kato K, Uemura A. Oral-mucosal administration of IFNalpha potentiates immune response in mice. J Interferon Cytokine Res. 1998; 18(9):661-6. PMID: 9781804
37. Marcus PI, Girshick T, van der Heide L, Sekellick MJ. Super-sentinel chickens and detection of low-pathogenicity influenza virus. Emerg Infect Dis. 2007; 13(10):1608-10. doi: 10.3201/eid1310.061552 PMID: 18258021
38. Braun D, Caramalho I, Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol. 2002; 14(4):411-9. PMID: 11934877
39. Wang Y, Tian Q, Xu X, Yang X, Luo J, Mo W, et al. Recombinant rabies virus expressing IFNα1 enhanced immune responses resulting in its attenuation and stronger immunogenicity. Virology. 2014; 468-470:621-30. doi: 10.1016/j.virol.2014.09.010 PMID: 25310498
40. Penski N, Hartle S, Rubbenstroth D, Krohmann C, Ruggli N, Schusser B, et al. Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state. J Virol. 2011; 85(15):7730-41. doi: 10.1128/JVI.00063-11 PMID: 21613402
41. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007; 6(12):975-90. PMID: 18049472
42. Sen GC, Peters GA. Viral stress-inducible genes. Adv Virus Res. 2007; 70:233-63. PMID: 17765707
43. Pulit-Penaloza JA, Scherbik SV, Brinton MA. Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells. Virology. 2012; 425(2):82-94. doi: 10.1016/j.virol.2012.01.006 PMID: 22305622
44. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, et al. Suppression of the antiviral response by an influenza histone mimic. Nature. 2012; 483(7390):428-33. doi: 10.1038/nature10892 PMID: 22419161
45. Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. MBio. 2014; 5(3):e01174-14. doi: 10.1128/mBio.01174-14 PMID: 24846384 46.
46. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001; 69(6):912-20. PMID: 11404376
47. Wright P, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe D, Howley P, editors. Fields Virology. 1. Philadelphia: Lippincott; 2013. p. 1186-243.
48. Kim Y, Thapa M, Hua DH, Chang KO. Biodegradable nanogels for oral delivery of interferon for norovirus infection. Antiviral Res. 2011; 89(2):165-73. doi: 10.1016/j.antiviral.2010.11.016 PMID: 21144866
49. Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, Tam JS, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol. 2008; 15(7):1042-53. doi: 10.1128/CVI.00397-07 PMID: 18448618
50. Nfon C, Berhane Y, Pasick J, Kobinger G, Kobasa D, Babiuk S. Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2. Vaccine. 2012; 30 (50):7187-92. doi: 10.1016/j.vaccine.2012.10.021 PMID: 23084852
51. Sasaki S, Holmes TH, Albrecht RA, García-Sastre A, Dekker CL, He XS, et al. Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines. J Infect Dis. 2014; 210(6):865-74. doi: 10.1093/infdis/jiu190 PMID: 24676204
52. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011; 12(8):786-95. doi: 10.1038/ni.2067 PMID: 21743478